Sign in to continue:

Thursday, April 9th, 2026

Category: us corporate news

Contango ORE, Inc. 2025 Annual Report: Business Overview, Risk Factors, and Strategic Developments

Contango ORE, Inc. 2025 Annual Report – Investor Analysis ...

CytomX Therapeutics 2025 Annual Report: Business Overview, Clinical Pipeline, and Financial Highlights

CytomX Therapeutics, Inc. 2025 Annual Report: Investor-Focus...

Coya Therapeutics: Advancing Treg-Based Therapies for Neurodegenerative and Autoimmune Diseases

Coya Therapeutics, Inc. 2025 Annual Report – Investor Summar...